Search Results 61-70 of 74 for ⚠라인010인증 TG @KORID010 010 모든계정 파일화가능⚠

  1. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) - Mayo Clinic

    The purpose of this study is to evaluate the safety and efficacy of [177Lu]Lu-FAP-2286 as monotherapy in participants with pancreatic ductal adenocarcinoma ( ...

  2. A Study to Evaluate Topical VT30 to Treat Patients with Venous/Lymphatic Malformations Associated with PIK3CA or TEK Gene Mutations - Mayo Clinic

    Part 2 is a 12-week treatment, randomized, placebo-controlled, double-blind, safety and exploratory effectiveness study. Part 2 will be initiated only after the ...

  3. Hyperthermic Chemotherapy For Gastric Cancer At High Risk Of Peritoneal Recurrence - Mayo Clinic

    About this study. The purpose of this study is to evaluate the reduction in the peritoneal recurrence at 18 months for patients receiving p-HIPEC.

  4. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma - Mayo Clinic

    This condition is referred to as "in-transit metastases" or "ITM." Immunotherapy with STI-3031 may help the body's immune system attack the cancer, and may ...

  5. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  6. A Rollover Extension Program (Rep) to Evaluate the Long-Term Safety AndTolerability of Open Label Iptacopan in Adult Participants With Primary Iga Nephropathy - Mayo Clinic

    About this study. The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan 200 mg b.i.d. in primary IgA ...

  7. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic leukemia that has returned after a ...

  8. A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer - Mayo Clinic

    Safety is the primary objective of this study, followed by effectiveness that will be assessed from fluorescence imaging observations and data. Participation ...

  10. A Study to Evaluate Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors - Mayo Clinic

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...